Therapeutic Response

CD20 + status confers therapeutic sensitivity to Corticosteroid in combination with Cyclophosphamide, Cytarabine, Doxorubicin, Etoposide, Methotrexate, Rituximab, and Vincristine in patients with Diffuse Large B-Cell Lymphoma.

Statements

Source and description